Companies / Ionis Pharmaceuticals Inc / Activity
Activity — Ionis Pharmaceuticals Inc
251 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | Bennett C Frank Executive | Exercise | Common Stock | $0 | +21K +25.47% | 103,734 0.06% of shares | low |
| Feb 2, 2026 | Bennett C Frank Executive | Other | Common Stock | $0 | 0 0.00% | 100,293 0.06% of shares | low |
| May 4, 2026 | Loscalzo Joseph Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -16K -100.00% | 0 0.00% of shares | low |
| May 4, 2026 | Loscalzo Joseph Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -12K -100.00% | 0 0.00% of shares | low |
| May 4, 2026 | Loscalzo Joseph Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -16K -100.00% | 0 0.00% of shares | low |
| May 4, 2026 | Loscalzo Joseph Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -10K -100.00% | 0 0.00% of shares | low |
| May 4, 2026 | Loscalzo Joseph Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -12K -100.00% | 0 0.00% of shares | low |
| May 4, 2026 | Loscalzo Joseph Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -11K -100.00% | 0 0.00% of shares | low |
| May 1, 2026 | Klein Joseph III Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -10K -100.00% | 0 0.00% of shares | low |
| Apr 1, 2026 | Klein Joseph III Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -10K -100.00% | 0 0.00% of shares | low |
| Apr 1, 2026 | Klein Joseph III Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -12K -100.00% | 0 0.00% of shares | low |
| Jun 15, 2026 | Berthelsen Spencer R Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -8K -100.00% | 0 0.00% of shares | low |
| Jun 1, 2026 | Berthelsen Spencer R Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -8K -50.00% | 8,000 <0.01% of shares | low |
| Jan 15, 2026 | Kordasiewicz Holly B. Executive | Grant | Restricted Stock Unit | — | +11K +32.63% | 45,730 0.03% of shares | low |
| Jan 15, 2026 | Kordasiewicz Holly B. Executive | Grant | Restricted Stock Unit | — | +14K +65.53% | 34,480 0.02% of shares | low |
| Jan 15, 2026 | Kordasiewicz Holly B. Executive | Exercise | Restricted Stock Unit | — | -11K -34.80% | 20,830 0.01% of shares | low |
| Jan 2, 2026 | Kordasiewicz Holly B. Executive | Grant | Non-Qualified Stock Option (right to buy) | — | +8K +82.42% | 16,600 <0.01% of shares | low |
| Mar 3, 2026 | Devers Shannon L. Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -385 -4.16% | 8,877 <0.01% of shares | low |
| Mar 3, 2026 | Devers Shannon L. Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -4K -25.00% | 11,280 <0.01% of shares | low |
| Mar 3, 2026 | Devers Shannon L. Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -4K -37.93% | 5,744 <0.01% of shares | low |
| Mar 3, 2026 | Devers Shannon L. Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -6K -25.00% | 16,500 <0.01% of shares | low |
| Mar 3, 2026 | Devers Shannon L. Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -7K -88.22% | 928 <0.01% of shares | low |
| Jan 15, 2026 | Devers Shannon L. Executive | Grant | Restricted Stock Unit | — | +10K +22.48% | 52,704 0.03% of shares | low |
| Jan 15, 2026 | Devers Shannon L. Executive | Exercise | Restricted Stock Unit | — | -17K -28.77% | 43,029 0.03% of shares | low |
| Jan 15, 2026 | Devers Shannon L. Executive | Grant | Performance Restricted Stock Units | — | +26K +117.27% | 47,800 0.03% of shares | low |
| Jan 7, 2026 | Devers Shannon L. Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -26K -89.58% | 2,971 <0.01% of shares | low |
| Jan 7, 2026 | Devers Shannon L. Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -9K -50.01% | 9,262 <0.01% of shares | low |
| Jan 7, 2026 | Devers Shannon L. Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -4K -29.27% | 9,254 <0.01% of shares | low |
| Jan 7, 2026 | Devers Shannon L. Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -3K -30.51% | 7,879 <0.01% of shares | low |
| Jan 7, 2026 | Devers Shannon L. Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -2K -15.63% | 11,339 <0.01% of shares | low |
| Jan 15, 2026 | Birchler Brian Executive | Grant | Restricted Stock Unit | — | +10K +23.53% | 50,801 0.03% of shares | low |
| Jan 15, 2026 | Birchler Brian Executive | Exercise | Restricted Stock Unit | — | -20K -32.82% | 41,126 0.02% of shares | low |
| Jan 15, 2026 | Birchler Brian Executive | Grant | Performance Restricted Stock Units | — | +26K +48.37% | 79,138 0.05% of shares | low |
| Jan 2, 2026 | Kordasiewicz Holly B. Executive | Grant | Non-Qualified Stock Option (right to buy) | — | +9K | 9,100 <0.01% of shares | low |
| Jan 2, 2026 | Devers Shannon L. Executive | Grant | Non-Qualified Stock Option (right to buy) | — | +19K | 19,350 0.01% of shares | low |
| Jan 2, 2026 | Birchler Brian Executive | Grant | Non-Qualified Stock Option (right to buy) | — | +19K | 19,350 0.01% of shares | low |
| Jan 15, 2026 | Schneider Eugene Executive | Grant | Restricted Stock Unit | — | +10K +24.65% | 48,926 0.03% of shares | low |
| Jan 15, 2026 | Schneider Eugene Executive | Exercise | Restricted Stock Unit | — | -22K -35.59% | 39,251 0.02% of shares | low |
| Jan 15, 2026 | Schneider Eugene Executive | Grant | Performance Restricted Stock Units | — | +26K +39.43% | 91,237 0.05% of shares | low |
| Jan 2, 2026 | Schneider Eugene Executive | Grant | Non-Qualified Stock Option (right to buy) | — | +19K | 19,350 0.01% of shares | low |
| Mar 4, 2026 | Baroldi Joseph Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -238 -5.80% | 3,866 <0.01% of shares | low |
| Mar 3, 2026 | Baroldi Joseph Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -820 -16.65% | 4,104 <0.01% of shares | low |
| Mar 4, 2026 | Baroldi Joseph Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -201 -10.20% | 1,769 <0.01% of shares | low |
| Mar 3, 2026 | Baroldi Joseph Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -879 -30.85% | 1,970 <0.01% of shares | low |
| Jan 15, 2026 | Baroldi Joseph Executive | Grant | Restricted Stock Unit | — | +4K +71.25% | 9,374 <0.01% of shares | low |
| Jan 15, 2026 | Baroldi Joseph Executive | Exercise | Restricted Stock Unit | — | -3K -34.24% | 5,474 <0.01% of shares | low |
| Jan 15, 2026 | Baroldi Joseph Executive | Grant | Restricted Stock Unit | — | +10K +19.56% | 59,149 0.04% of shares | low |
| Jan 15, 2026 | Baroldi Joseph Executive | Exercise | Restricted Stock Unit | — | -17K -25.62% | 49,474 0.03% of shares | low |
| Jan 15, 2026 | Baroldi Joseph Executive | Grant | Performance Restricted Stock Units | — | +26K +50.30% | 77,090 0.05% of shares | low |
| Jan 2, 2026 | Baroldi Joseph Executive | Grant | Non-Qualified Stock Option (right to buy) | — | +3K | 2,600 <0.01% of shares | low |